Centene Corp. (NYSE:CNC) is one of the most oversold S&P 500 stocks so far in 2025. On July 2, Centene’s share price plunged ...

The Clayton-based health giant is likely to face increased challenges as federal government tightens Medicaid eligibility and ...

Centene is trading at half of book value and under 9x earnings, an extreme undervaluation for a cash-generating insurer. See why I rate CNC stock a Buy.

Government-run health care programs fueled the rise of Centene Corp., but cuts to federal assistance could cause it to slide. Centene has grown to be the largest Medicaid managed care provider in the ...

Nearly a week ago, shares of Centene closed down 40.4%, making it the largest single-day drop since the company went public ...

Shares of Centene are trading lower on Thursday, hitting a new 52-week low. A rival's profit warning fueled investor anxiety ...

An estimated 1.3 million people in New York are at risk of losing their Medicaid coverage in the next decade due to Trump's ...

As the leading provider of Medicaid and individual exchange plans, Centene appears in the cross-hairs of these regulatory moves under Republicans, which puts roughly 17 million people at risk of ...

Centene's headwinds could intensify after Congress passed a bill that aims to cut Medicaid spending starting in 2027 and allows individual plan subsidies at the end of 2025.

Centene stock falls on fear of Medicaid cuts, CEO sounds optimistic note. expand. Sarah London, CEO of Centene Corp. Michael Thomas. By James Drew – Reporter, St. Louis Business Journal.

Centene has been working to enroll people back into its Medicaid plans after the end of pandemic-relief measures left hundreds of thousands of ... Centene to cut about 2,000 jobs. Reuters. ...

Health insurer Centene will lay off 3% of its workforce, ... Centene to cut about 2,000 jobs. By Reuters. ... which makes a major chunk of its revenue from government-backed Medicaid memberships, ...